Published by Josh White on 3rd June 2021
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced the publication of research supporting the immunotherapeutic blockade of 'Clever-1' to activate anti-tumour immune responses in advanced cancer patients on Thursday.
URL: http://www.digitallook.com/dl/news/story/31893974/...